
These women dedicated almost 50 years to science. Their efforts may soon be trashed
Food & healthFacebookTweetLink
Follow
For decades, researchers have been collecting samples from hundreds of thousands of women and tracking their health. The work has deepened our basic understanding of human health, but now the entire project is in danger.
When nurses Patricia Chubb, 70, and her mother, Charlotte Mae Rohrbaugh, 98, joined the fledgling Harvard University-led Nurses' Health Study in 1976, they had no idea it would last for nearly 50 years.
'It's probably the longest, if not one of the longest, prospective health care studies for women that's ever been done,' said Chubb, who lives in Pennsylvania. 'They picked nurses to do the study because they know how to answer health questions correctly and can draw their own blood and the like — it's very cost-effective.'
Study data gathered through the years from some 280,000 nurses in the United States has contributed enormously to improving how we live. The work has informed dietary recommendations, including national dietary guidelines; led to hormonal therapies for breast cancer prevention and treatment; and contributed to research about how nutrients, inflammatory markers and heavy metals influence disease development.
Yet all of that priceless data may soon be discarded due to President Donald Trump's ongoing feud with Harvard over what Trump claims is a failure to protect Jewish students during campus protests.
On Monday, an investigation by the Trump administration claimed that Harvard was in 'violent violation' of the Civil Rights Act by being 'deliberately indifferent' or a 'willful participant in anti-Semitic harassment of Jewish students, faculty, and staff.'
Harvard strongly disagreed with the administration's claims.
Interestingly, Trump had posted on Truth Social on June 20 that Harvard had 'acted extremely appropriately' during negotiations and that he was close to a 'Deal' with the university that would 'be 'mindbogglingly' HISTORIC, and very good for our Country.'
But then, in the letter sent to Harvard on Monday, Trump officials made it clear Harvard would continue to lose 'all federal financial resources,' including millions for research, if the university did not comply with the administration's wishes.
Funding for the Nurses' Health Study and its companion study for men, the Health Professionals Follow-up Study, had already been abruptly withdrawn in mid-May, said Harvard nutritionist Dr. Walter Willett, who has led the studies since 1980.
Willett and his team were left scrambling to find the funds needed to protect freezers stocked with stool, urine and DNA specimens gathered from thousand of nurses for nearly five decades. Just the liquid nitrogen needed to keep the specimens frozen costs thousands of dollars a month.
'Of course, we would all love to have an agreement that lets us get on with research, education, and working to improve the health and well-being of everyone.' said Willett, a professor of epidemiology and nutrition at Harvard T.H. Chan School of Public Health in Boston, who has published over 2,000 papers on nutrition.
'But this can't happen if we turn over admissions, faculty hiring and curriculum to governmental control.'
Twenty-one-year-old Jackie Desmond joined the Harvard-based study when she graduated from nursing school in 1978. She considered the research so valuable that she later enrolled her 9-year-old son Kyle in a spin-off study investigating family nutrition. At 41, he still participates.
'They send us questionnaires once or twice a year about lifestyle and nutrition, what medications you're on, your lifestyle habits, when you sleep, when you eat, everything,' Desmond said. 'I've sent them samples of blood, urine, feces, whatever they need.' The study even has solicited toenails, which carry markers of heavy metals.
One reason the study was so special is it was only focused on women, said Desmond, who is now 68 and lives in Connecticut.
'Before that, most studies were done only on men. So, it was about time to focus on studying women and they came up with some amazing information that's been very helpful to many of us,' Desmond said.
'You know for that reason alone, these samples are irreplaceable — losing them might put women's health research back many years,' she added.
For Desmond and Chubb, the cuts in research funding make no sense.
'There's no connection in my mind between antisemitism and medical research. Why are you getting rid of decades of research? It's infuriating,' Desmond said. 'And it's very personal — I guess they'll just toss my DNA into the dump.'
The threats to cuts also arrive as the Trump administration pushes its 'Make American Healthy Again' initiative, which Chubb finds ironic.
'You know what? There's lots of research going on to get us healthier and keep us healthier, and those are cuts that should not be made,' Chubb said. 'It's so shortsighted to shoot first and aim later.'
Data from the Nurses' Health Study has vastly improved how all Americans live and eat while also impacting the health of people around the world, Willett said.
'From the efforts of these dedicated nurses we learned trans fats were terrible for health, and now those are basically gone from our food supply,' he said. 'We also found one of the earliest links between cigarette smoking and heart disease.'
Data from the nurses' studies found red meat and alcohol can lead to breast cancer in women. Other key findings also proved lifestyle choices can improve health — the research identified diets that may reduce risk of cognitive decline.
A list of scientific advances produced from the Nurses' Health Study data appears on its website.
Dorothy Dodds, who died at 83, joined the original study in 1976. When her daughter Martha became a nurse in 1982, she joined the second wave of research, called the Nurses' Health Study II. A third generation of the study is still enrolling participants — the Nurses' Health Study 3.
For Martha Dodds, now 68, her family's years of dedication to the study is priceless.
'You know, nurses don't get paid a lot,' Dodds said. 'We do our work because we want to help others. We took the study seriously and were careful and honest with our answers.
'My one little part may have helped women cut down on alcohol consumption, or maybe it'll help both men and women exercise more and cut back on trans fats,' Dodds added.
All of the nurses CNN spoke with consider their years of dedication to the Nurses' Health Study a lifetime accomplishment.
'I'm so proud to be a participant, I'll put it in my obituary,' Chubb said. 'And my 98-year-old mom — who's still got all her faculties, and some of other people's, too — has chosen the Nurses' Health Study for donations in lieu of flowers in her funeral plans.'
Chubb and her mother are in good company. Families of nurses across the country have proudly listed their Nurses' Health Study participation in their obituaries: Karen Ann Mudgett from Michigan, Donna Palmer from Georgia, Jeanette Thomas from Pennsylvania, Mary Ellen Natale from New Jersey, Patricia Anne Cobb from California, Marion Jones from Florida, Irene Rees from Virginia and many more.
'And now these hundreds of thousands of hours of work by nearly 300,000 nurses will just be discarded?' Dodds said. 'We're going to take 50 years of research and all this biodata and just destroy it, make it useless?
'It's like burning the Library of Congress — you just can't get that back.'
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
BridgeBio (BBIO) Tanks After Selling Beyonttra Royalty Rights
BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the . BridgeBio Pharma dropped for a second day on Monday, shedding 3.74 percent to finish at $43.18 apiece as investors digested the sale of royalty rights from its heart drug Beyonttra. In a statement, BridgeBio Pharma, Inc. (NASDAQ:BBIO) said that it secured $300 million in fresh funds from HealthCare Royalty funds—an investment company managed by Blue Owl—for the sale of 60 percent royalty rights from Beyonttra's first $500 million sales in Europe. Last year, BridgeBio Pharma, Inc. (NASDAQ:BBIO) entered into an exclusive licensing agreement with Bayer Consumer Care AG to commercialize Beyonttra in Europe, with the former raising $210 million in upfront payment with expectations to receive $75 million in near-term milestone payments. Beyonttra is an orally administered near-complete stabilizer of transthyretin indicated for the treatment of wild-type or variant transthyretin amyloidosis in adult patients with cardiomyopathy. A team of scientists in white lab coats reviewing lab results in a research facility. While we acknowledge the potential of BBIO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio


The Hill
an hour ago
- The Hill
20 states sue over Medicaid data release to ICE officials
A coalition of 20 Democrat-led states is suing the Trump administration for sharing Medicaid data with immigration officials, arguing it violates privacy protections. The suit, spearheaded by Californian and filed Tuesday, argues the Trump administration violated the law in sharing data with U.S. Immigration and Customs Enforcement (ICE) that had nothing to do with administering the health care program. 'The Trump Administration has upended longstanding privacy protections with its decision to illegally share sensitive, personal health data with ICE. In doing so, it has created a culture of fear that will lead to fewer people seeking vital emergency medical care,' said California Attorney General Rob Bonta. 'I'm sickened by this latest salvo in the President's anti-immigrant campaign. We're headed to court to prevent any further sharing of Medicaid data — and to ensure any of the data that's already been shared is not used for immigration enforcement purposes.' The states argue that failure to notify them of data sharing plans violates the Administrative Procedures Act as well as the Social Security Act; the Health Insurance Portability and Accountability Act, or HIPAA; the Federal Information Security Modernization Act and the Privacy Act. The data transfer, first reported by The Associated Press last month, showed that Medicaid officials unsuccessfully sought to block the data transfer, citing legal and ethical concerns. Nevertheless, two top advisers to Health Secretary Robert F. Kennedy Jr. ordered the dataset handed over to the Department of Homeland Security, the emails show. Officials at the Centers for Medicare and Medicaid Services were given just 54 minutes on Tuesday to comply with the directive. The dataset includes the information of people living in California, Illinois, Washington state and Washington, D.C., all of which allow non-U.S. citizens to enroll in Medicaid programs that pay for their expenses using only state taxpayer dollars. The move comes as the Trump administration has used a number of moves to target migrants, including those with lawful status in the U.S. ICE agents have been conducting arrests of migrants after those in immigration court leave hearings, prompting critiques from Democrats that the Trump administration is targeting those seeking to immigrate through lawful pathways. The Trump administration has sought to tap a number of databases to gain information about migrants, including IRS data. —The Associated Press contributed.


Politico
an hour ago
- Politico
It's Medicaid decision time for these House moderates
The House Republicans who pledged to protect Medicaid, many of whom represent large shares of enrollees, are facing intense pressure from President Donald Trump to pass it before July 4th — his self-imposed deadline. 'The American people need and deserve it,' Trump posted Tuesday on his social media site, Truth Social. Some GOP senators who said they opposed big Medicaid cuts, most prominently Missouri's Josh Hawley, ultimately voted for the bill. Two others voted no: Susan Collins of Maine and Thom Tillis of North Carolina. The House's version of the bill would freeze the states' current provider tax rates — which they levy on hospitals to juice the federal contribution. The more money a state devotes to Medicaid, the greater amount of federal dollars it can qualify for, and the taxes ensure a state can cover its share of Medicaid costs without dipping into their own funds. The Senate version keeps the freeze for the 10 states that haven't taken advantage of an Obamacare provision encouraging states to expand Medicaid to cover lower-middle-income people with a generous federal match. But it cuts the amount expansion states can levy from 6 percent of a provider's revenue to 3.5 percent. The bill starts to phase down the tax cap in 2028. House moderates are furious with the change, alongside a clampdown on a similar tool called state-directed payments. Sixteen House Republicans wrote to Senate Majority Leader John Thune in late June, saying they won't support the legislation if it cuts the provider taxes and state-directed payments. The hospital industry has also bombarded House lawmakers, saying the provisions will cause facilities to close, especially in rural areas. Democrats are already saying Republicans are shredding the social safety net to extend tax cuts for the wealthy. As in the Senate, House Republicans can lose no more than three votes if Democrats remain united in opposition. Here are six GOP lawmakers to watch: Rep. Don Bacon speaks to reporters on his way to a closed-door GOP caucus meeting at the U.S. Capitol, on Jan. 10, 2023. |Don Bacon, Nebraska's 2nd District